Sutro Biopharma Inc buy Piper Sandler
Start price
03.04.24
/
50%
€4.78
Target price
03.04.25
€10.16
Performance (%)
-26.78%
Price
06.05.24
€3.58
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -26.78%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | 9.816% | 9.816% |
iShares Core DAX® | 0.476% | -0.039% |
iShares Nasdaq 100 | 1.290% | 0.504% |
iShares Nikkei 225® | 1.300% | -2.135% |
iShares S&P 500 | 0.829% | 0.193% |
Comments by Piper_Sandler for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $11.00 price target on the stock, down previously from $12.00.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Piper_Sandler for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.28
15.11.23
15.11.23
€11.04
15.11.24
15.11.24
57.02%
06.05.24
06.05.24